Modutech S.A.

Switzerland

Back to Profile

1-4 of 4 for Modutech S.A. Sort by
Query
Aggregations
Jurisdiction
        United States 2
        World 2
IPC Class
A61K 36/16 - Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family) 4
A61K 36/258 - Panax (ginseng) 4
A61K 36/28 - Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea 4
A61K 36/815 - Lycium (desert-thorn) 4
A61K 36/82 - Theaceae (Tea family), e.g. camellia 4
See more
Found results for  patents

1.

Preparation comprising amino acids and plants and its activity in the alcohol detoxification

      
Application Number 14245355
Grant Number 09192638
Status In Force
Filing Date 2014-04-04
First Publication Date 2014-08-07
Grant Date 2015-11-24
Owner
  • Modutech S.A. (Switzerland)
  • Hangzhou Adamerck Pharmlabs Inc. (China)
Inventor
  • Qi, Youmao
  • Jie, Qing
  • Zhang, Fengmin
  • Gu, Ying
  • Yu, Meiping

Abstract

ginkgo biloba leaf, the extract of Silibinin, the extract of barberry wolfberry fruit and tea polyphenosis. The invention also relates to the biological activities of said preparation, such as the liver protection from chemical injury, the tolerance enhancement of hypoxy and the rapid decrease till elimination of the blood alcohol content.

IPC Classes  ?

  • A61K 36/25 - Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
  • A61K 36/16 - Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
  • A61K 36/00 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
  • A61K 36/28 - Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
  • A23L 1/30 - containing additives (A23L 1/308 takes precedence);;
  • A23L 1/305 - Amino acids, peptides or proteins 
  • A61K 9/08 - Solutions
  • A61K 9/20 - Pills, lozenges or tablets
  • A61K 31/198 - Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
  • A61K 31/405 - Indole-alkanecarboxylic acidsDerivatives thereof, e.g. tryptophan, indomethacin
  • A61K 36/258 - Panax (ginseng)
  • A61K 36/815 - Lycium (desert-thorn)
  • A61K 36/82 - Theaceae (Tea family), e.g. camellia
  • A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
  • A61K 31/357 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel

2.

Preparation comprising amino acids and plants and its activity in the alcohol detoxification

      
Application Number 13504756
Grant Number 09526753
Status In Force
Filing Date 2010-10-28
First Publication Date 2012-10-25
Grant Date 2016-12-27
Owner
  • MODUTECH S.A. (Switzerland)
  • HANGZHOU ADAMERCK PHARMSLABS INC. (China)
Inventor
  • Qi, Youmao
  • Jie, Qing
  • Zhang, Fengmin
  • Gu, Ying
  • Yu, Meiping

Abstract

ginkgo biloba leaf, the extract of Silibinin, the extract of barbury wolfberry fruit and tea polyphenols. The invention also relates to the biological activities of said preparation, such as the liver protection from chemical injury, the tolerance enhancement of hypoxy and the rapid decrease till elimination of the blood alcohol content.

IPC Classes  ?

  • A61K 36/28 - Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
  • A61K 9/08 - Solutions
  • A61K 9/20 - Pills, lozenges or tablets
  • A61K 31/198 - Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
  • A61K 31/405 - Indole-alkanecarboxylic acidsDerivatives thereof, e.g. tryptophan, indomethacin
  • A61K 36/16 - Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
  • A61K 36/258 - Panax (ginseng)
  • A61K 36/815 - Lycium (desert-thorn)
  • A61K 36/82 - Theaceae (Tea family), e.g. camellia
  • A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
  • A61K 31/357 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel

3.

PREPARATION COMPRISING AMINO ACIDS AND PLANTS AND ITS ACTIVITY IN THE ALCOHOL DETOXIFICATION

      
Application Number IB2010054885
Publication Number 2011/051900
Status In Force
Filing Date 2010-10-28
Publication Date 2011-05-05
Owner
  • MODUTECH S.A. (Switzerland)
  • HANGZHOU ADAMERCK PHARMLABS INC. (China)
Inventor
  • Qi, Youmao
  • Jie, Qing
  • Zhang, Fengmin
  • Gu, Ying
  • Yu, Meiping

Abstract

The invention relates to a preparation containing several amino acids and plant extracts and its alcohol detoxification activity. The component (a) in the preparation contains a mixture of two or more amino acids or derivatives thereof; the component (b) in the preparation contains a mixture of three or more extracts from plants. There are several plant extracts used in this invention such as the extract of ginseng radix, the extract of ginkgo biloba leaf, the extract of Silibinin, the extract of barbury wolfberry fruit and tea polyphenols. The invention also relates to the biological activities of said preparation, such as the liver protection from chemical injury, the tolerance enhancement of hypoxy and the rapid decrease till elimination of the blood alcohol content.

IPC Classes  ?

  • A61K 36/258 - Panax (ginseng)
  • A61K 36/815 - Lycium (desert-thorn)
  • A61K 36/16 - Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
  • A61K 36/28 - Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
  • A61K 36/82 - Theaceae (Tea family), e.g. camellia
  • A61K 31/195 - Carboxylic acids, e.g. valproic acid having an amino group
  • A61P 1/16 - Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
  • A61P 9/10 - Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

4.

PREPARATION COMPRISING AMINO ACIDS AND PLANTS AND ITS ACTIVITY IN THE ALCOHOL DETOXIFICATION

      
Application Number IB2009007253
Publication Number 2011/051742
Status In Force
Filing Date 2009-10-28
Publication Date 2011-05-05
Owner
  • MODUTECH S.A. (Switzerland)
  • HANGZHOU ADAMERCK PHARMLABS INC. (China)
Inventor
  • Qi, Youmao
  • Jie, Qing
  • Zhang, Fengmin
  • Gu, Ying
  • Yu, Meiping

Abstract

The invention relates to a preparation containing several amino acids and plant extracts and its alcohol detoxification activity. The component (a) in the preparation contains a mixture of two or more amino acids or derivatives thereof; the component (b) in the preparation contains a mixture of three or more extracts from plants. There are several amino acids used in the present invention such as citrulline, ornithine, arginine, threonine, tryptophan or 5- hydroxytryptophan. There are several plant extracts used in this invention such as the extract of ginseng radix, the extract of ginkgo biloba leaf, the extract of Silibinin, the extract of barbury wolfberry fruit and tea polyphenols. The invention also relates to the biological activities of said preparation, such as the liver protection from chemical injury, the tolerance enhancement of hypoxy and the rapid decrease till elimination of the blood alcohol content.

IPC Classes  ?

  • A61K 36/258 - Panax (ginseng)
  • A61K 36/815 - Lycium (desert-thorn)
  • A61K 36/16 - Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
  • A61K 36/28 - Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
  • A61K 36/82 - Theaceae (Tea family), e.g. camellia
  • A61K 31/195 - Carboxylic acids, e.g. valproic acid having an amino group
  • A61P 1/16 - Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
  • A61P 9/10 - Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis